Cargando…

Computational analysis of pathological images enables a better diagnosis of TFE3 Xp11.2 translocation renal cell carcinoma

TFE3 Xp11.2 translocation renal cell carcinoma (TFE3-RCC) generally progresses more aggressively compared with other RCC subtypes, but it is challenging to diagnose TFE3-RCC by traditional visual inspection of pathological images. In this study, we collect hematoxylin and eosin- stained histopatholo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Jun, Han, Zhi, Mehra, Rohit, Shao, Wei, Cheng, Michael, Feng, Qianjin, Ni, Dong, Huang, Kun, Cheng, Liang, Zhang, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156652/ https://www.ncbi.nlm.nih.gov/pubmed/32286325 http://dx.doi.org/10.1038/s41467-020-15671-5

Ejemplares similares

Ultrasonographic Findings of Renal Cell Carcinomas Associated with Xp11.2 Translocation/TFE3 Gene Fusion
por: Ling, Wenwu, et al.
Publicado: (2017)

Postoperative recurrence of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion
por: Wang, Zhen, et al.
Publicado: (2017)

Xp11.2 Translocation Renal Cell Carcinoma With TFE3 Rearrangement: Distinct Morphological Features and Prognosis With Different Fusion Partners
por: Ge, Yan, et al.
Publicado: (2021)

Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions: Clinical Features, Treatments and Prognosis
por: Liu, Ning, et al.
Publicado: (2016)

Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation/TFE3 gene fusion renal cell carcinomas
por: Zhou, Jiale, et al.
Publicado: (2022)

Clinical characteristics of XP11.2 translocation/TFE3 gene fusion renal cell carcinoma: a systematic review and meta-analysis of observational studies
por: Cheng, Xiangming, et al.
Publicado: (2016)

Preoperative neutrophil-to-lymphocyte ratio predicts the surgical outcome of Xp11.2 translocation/TFE3 renal cell carcinoma patients
por: Agizamhan, Sezim, et al.
Publicado: (2018)

Multimodality imaging of Xp11.2 translocation/TFE3 gene fusion associated with renal cell carcinoma: a case report
por: Huang, Wenpeng, et al.
Publicado: (2023)

Adult-onset renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: 3 case reports and review of literature
por: Gong, Pengfeng, et al.
Publicado: (2018)

Magnetic Resonance Imaging and Computed Tomography Characteristics of Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusion
por: Wang, Wei, et al.
Publicado: (2014)

Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusion: A Rare Case Report with Review of the Literature
por: Ahluwalia, Puneet, et al.
Publicado: (2013)

Dynamic Contrast-Enhanced CT Characterization of Xp11.2 Translocation/TFE3 Gene Fusions versus Papillary Renal Cell Carcinomas
por: He, Jian, et al.
Publicado: (2015)

Case Report: TFE3 Positive Xp11.2 Translocation Renal Cell Carcinoma (TRCC) – A Case Study and Review of the Literature
por: Miroński, Ignacy, et al.
Publicado: (2022)

The Transition From Localized to Metastatic: A Case Report of Adult TFE3-Positive Xp11.2 Translocation Renal Cell Carcinoma
por: Naviwala, Mohammad Saad, et al.
Publicado: (2023)

Temsirolimus in the treatment of renal cell carcinoma associated with Xp11.2 translocation/TFE gene fusion proteins: a case report and review of literature
por: Parikh, Jigarkumar, et al.
Publicado: (2009)

Clinicopathological features of Xp11.2 translocation renal cell carcinoma
por: Lim, Bumjin, et al.
Publicado: (2015)

Xp11.2 translocation renal cell carcinomas in young adults
por: Xu, Linfeng, et al.
Publicado: (2015)

Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma
por: Pradhan, Dinesh, et al.
Publicado: (2015)

Both SUMOylation and ubiquitination of TFE3 fusion protein regulated by androgen receptor are the potential target in the therapy of Xp11.2 translocation renal cell carcinoma
por: Liu, Ning, et al.
Publicado: (2022)

Xp11.2 Translocation Renal Cell Carcinoma Diagnosed by Immunohistochemistry and Cytogenetics
por: Dey, Biswajit, et al.
Publicado: (2016)

A Rare Partner of TFE3 in the Xp11 Translocation Renal Cell Carcinoma: Clinicopathological Analyses and Detection of MED15-TFE3 Fusion
por: Ye, Hong, et al.
Publicado: (2019)

Clinical and pathological heterogeneity of four common fusion subtypes in Xp11.2 translocation renal cell carcinoma
por: Guo, Wei, et al.
Publicado: (2023)

TFE3 fusions escape from controlling of mTOR signaling pathway and accumulate in the nucleus promoting genes expression in Xp11.2 translocation renal cell carcinomas
por: Yin, Xiaoqin, et al.
Publicado: (2019)

Bilateral Xp11.2 translocation renal cell carcinoma: a case report
por: Karashima, Takashi, et al.
Publicado: (2018)

Estrogen associates with female predominance in Xp11.2 translocation renal cell carcinoma
por: Lu, Yanwen, et al.
Publicado: (2023)

Newly Designed Break-Apart and ASPL-TFE3 Dual-Fusion FISH Assay Are Useful in Diagnosing Xp11.2 Translocation Renal Cell Carcinoma and ASPL-TFE3 Renal Cell Carcinoma: A STARD-Compliant Article
por: Chen, Xiancheng, et al.
Publicado: (2015)

Case Report: Clinical complete response of advanced renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion by treated by camrelizumab and axitinib: A rare case report
por: Zhao, Juping, et al.
Publicado: (2022)

Xp11.2 Translocation Renal Cell Carcinoma: A Rare Renal Cell Carcinoma
por: Kalita, Pranjal, et al.
Publicado: (2023)

Xp 11.2 translocation renal carcinoma in young adults; recently classified distinct subtype
por: Kmetec, Andrej, et al.
Publicado: (2014)

Xp11.2 Translocation Renal Cell Carcinoma: Clinical Characteristics and Potential Prognostic Predictors
por: Dong, Jie, et al.
Publicado: (2021)

PD-L1 expression in Xp11.2 translocation renal cell carcinoma: Indicator of tumor aggressiveness
por: Chang, Kun, et al.
Publicado: (2017)

Primary Xp11 translocation PEComa of the testis with SFPQ⁃TFE3 rearrangement: a case report and review of the literature
por: Zhang, Huizhi, et al.
Publicado: (2023)

Rapidly progressing renal cell carcinoma associated with Xp11.2 translocations: a case report
por: Morii, Akihiro, et al.
Publicado: (2012)

Contrast-enhanced ultrasound findings of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma
por: Wei, Shuping, et al.
Publicado: (2019)

Percutaneous radiofrequency ablation on a Xp11.2 Translocation Renal Cell Carcinoma: A case report
por: Kanas, Alexandre Fligelman, et al.
Publicado: (2020)

A new risk-scoring system to predict Xp11.2 translocation renal cell carcinoma in adults
por: Shi, Qiancheng, et al.
Publicado: (2021)

Phosphorylated 4EBP1 is associated with tumor progression and poor prognosis in Xp11.2 translocation renal cell carcinoma
por: Qu, Yuanyuan, et al.
Publicado: (2016)

Chemotherapy, transarterial chemoembolization, and nephrectomy combined treated one giant renal cell carcinoma (T3aN1M1) associated with Xp11.2/TFE3: A case report
por: Wang, Peng, et al.
Publicado: (2022)

Laparoscopic radiofrequency ablation-assisted enucleation of Xp11.2 translocation renal cell carcinoma: A case report
por: XU, LINFENG, et al.
Publicado: (2014)

Surgical treatment for Xp11.2 translocation renal cell carcinoma with venous thrombus: A STROBE-compliant study
por: Ge, Liyuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_eut7qsfaj33d2g8se5d6qjn0jp